Tag: BIO TECH

Clinical stage pharmaceutical company, Iterum Therapeutics (Nasdaq: ITRM) has announced positive topline results from its Phase 3 clinical trial comparing oral sulopenem to oral Augmentin®… [Read More]

Telemedicine-based therapy provider, Talkspace (Nasdaq: TALK), has partnered with Bicycle Health to expand their respective patients’ access to virtual care. Bicycle Health is the nation’s… [Read More]

Metabolic therapeutics company, Fractyl Health (Nasdaq: GUTS), began its first day of trading on Thursday last week with a mixed response from the market. The… [Read More]

Healthcare equities outperformed last week with Managed Care a standout. The S&P 500 Healthcare Index gained +1.98% versus the S&P 500 Index which was up… [Read More]

Atara Biotherapeutics (NASDAQ: ATRA), a biotech company at the forefront of developing off-the-shelf cell therapies using the natural power of the immune system, experienced a… [Read More]

Shares in medical technology company Intelligent Bio Solutions (Nasdaq: INBS) soared by more than 150% on Friday after the company reported its (unaudited) revenue results… [Read More]

  NeuroBo Pharmaceuticals (Nasdaq: NRBO) has received FDA clearance of its Investigational New Drug (IND) application for DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist… [Read More]

Vaccine innovation company, Vaxcyte (Nasdaq: PCVX) has announced pricing of a $750 million public offering which is expected to close on February 2, 2024. Last… [Read More]